BLFS
Price
$24.29
Change
-$0.06 (-0.25%)
Updated
Apr 24, 02:18 PM (EDT)
Capitalization
810.87M
14 days until earnings call
NVCR
Price
$17.80
Change
+$0.04 (+0.23%)
Updated
Apr 24, 02:41 PM (EDT)
Capitalization
1.66B
Earnings call today
Ad is loading...

BLFS vs NVCR

Header iconBLFS vs NVCR Comparison
Open Charts BLFS vs NVCRBanner chart's image
BioLife Solutions
Price$24.29
Change-$0.06 (-0.25%)
Volume$700
Capitalization810.87M
NovoCure
Price$17.80
Change+$0.04 (+0.23%)
Volume$100
Capitalization1.66B
BLFS vs NVCR Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. NVCR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and NVCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BLFS: $24.34 vs. NVCR: $17.77)
Brand notoriety: BLFS and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 159% vs. NVCR: 123%
Market capitalization -- BLFS: $810.87M vs. NVCR: $1.66B
BLFS [@Medical Specialties] is valued at $810.87M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 5 TA indicator(s) are bullish while NVCR’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 5 bullish, 5 bearish.
  • NVCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а +9.34% price change this week, while NVCR (@Medical Specialties) price change was +12.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.99%. For the same industry, the average monthly price growth was -6.85%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

NVCR is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+3.99% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than BLFS($811M). BLFS YTD gains are higher at: -6.240 vs. NVCR (-40.369). BLFS has higher annual earnings (EBITDA): -45.24M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. BLFS (51.7M). BLFS has less debt than NVCR: BLFS (42.7M) vs NVCR (596M). NVCR has higher revenues than BLFS: NVCR (509M) vs BLFS (143M).
BLFSNVCRBLFS / NVCR
Capitalization811M1.66B49%
EBITDA-45.24M-177.45M25%
Gain YTD-6.240-40.36915%
P/E Ratio238.10N/A-
Revenue143M509M28%
Total Cash51.7M911M6%
Total Debt42.7M596M7%
FUNDAMENTALS RATINGS
BLFS vs NVCR: Fundamental Ratings
BLFS
NVCR
OUTLOOK RATING
1..100
1116
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
5962
P/E GROWTH RATING
1..100
126
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLFS's Valuation (95) in the Medical Specialties industry is in the same range as NVCR (100). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as NVCR (100). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's SMR Rating (91) in the Medical Specialties industry is in the same range as NVCR (94). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's Price Growth Rating (59) in the Medical Specialties industry is in the same range as NVCR (62). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (6) in the Medical Specialties industry is in the same range as BLFS (12). This means that NVCR’s stock grew similarly to BLFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSNVCR
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSHVX35.790.33
+0.93%
Sound Shore Institutional
FRDPX83.08N/A
N/A
Franklin Rising Dividends A
NDVRX14.44N/A
N/A
MFS New Discovery Value R1
IJSAX12.16N/A
N/A
VY® JPMorgan Small Cap Core Equity A
ICTTX11.90N/A
N/A
ICON Health and Information Tech Inv

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+11.19%
RGEN - BLFS
55%
Loosely correlated
+1.78%
DHR - BLFS
47%
Loosely correlated
+2.21%
GH - BLFS
46%
Loosely correlated
+4.20%
VCYT - BLFS
46%
Loosely correlated
+1.08%
RVTY - BLFS
46%
Loosely correlated
+1.46%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with RVTY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+7.63%
RVTY - NVCR
36%
Loosely correlated
+1.46%
NEO - NVCR
36%
Loosely correlated
+1.44%
BLFS - NVCR
36%
Loosely correlated
+11.19%
TWST - NVCR
36%
Loosely correlated
+1.84%
FLGT - NVCR
36%
Loosely correlated
+2.49%
More